Aggregated intelligence for drug researchers

Written by Jo Lyon

What is claimed to be the first Web-based business intelligence service designed specifically for pharmaceutical and biotechnology companies involved in drug research goes live next month. Paracel Inc's BioView TODAY provides access to data from over 2500 sources, including those offered by DowVision, IAC's PROMT, Derwent Biotechnology Abstracts and IntellX.

According to Paracel, which develops news filtering software, BioView TODAY aims to provide the industry's managers, executives and scientists with Web-based access to breaking news on competitors, patents, scientific discoveries, regulatory developments and financial market information.

Advertisement

The site splits information into Today's News, Week in Review and a historical archive. Additionally, users can opt to run BioAlert! software, which provides a scrolling ticker with headlines and selected stock quotes. When a headline is selected, BioAlert! automatically launches the user's Web browser and displays the full text of the article.

Among the first companies to sign up with BioView is Perkin-Elmer Applied Biosystems, which will provide access to the service for 500 of its executives, managers and scientists. The site will be available for a fixed yearly subscription, although exact details have yet to be announced.

+1 972 789 1990

http://www.paracel.com.

Tags:

  • Have your say
  • Send to a friend
  • Share
  • Print

Comments

Also read

White papers

Related jobs

More Accounting jobs

Spotlight

The Top 50 +50 survey 2009

All the news, views and analysis on our 2009 Top...

Elizabeth Rumsey, Virgin Galactic's FD

Profile: Elizabeth Rumsey, Virgin Galactic's FD

While Richard Branson and his Virgin Galactic team chase the...

How To guides

The archive of Accountancy Age's How To guides

Find your next job

Find your next job
Salary Checker

Job of the week

More finance jobs

Newsletters

Sign up here for the very latest news delivered to your inbox. Choose from the following options:

Your next job

Have your say

Should chancellor Alistair Darling lose his job for claiming for tax advice?
Yes
No

Advertisement

Search white papers

Search white papers

Advertisement

Advertisement